This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

A Single-Center Pilot Study to Assess Macular Function

This study has been completed.
Information provided by (Responsible Party):
ORA, Inc. Identifier:
First received: September 16, 2010
Last updated: February 13, 2012
Last verified: February 2012
This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.

Macular Degeneration

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by ORA, Inc.:

Enrollment: 24
Study Start Date: September 2010
Study Completion Date: October 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Young normals
Older normals


Ages Eligible for Study:   20 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Three groups of subjects will be enrolled:

  1. Normal healthy subjects aged 20-29 years
  2. Normal healthy subjects aged 60-90 years
  3. Subjects with early dry AMD

Inclusion Criteria:

  • Subjects in good health aged 20-29 or 60-90 years (normal cohorts)
  • Subjects with early non-exudative age-related macular degeneration (AMD cohort)

Exclusion Criteria:

  • Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01204541

United States, Massachusetts
Andover, Massachusetts, United States, 01810
Sponsors and Collaborators
ORA, Inc.
  More Information

Responsible Party: ORA, Inc. Identifier: NCT01204541     History of Changes
Other Study ID Numbers: 10-120-0013
Study First Received: September 16, 2010
Last Updated: February 13, 2012

Keywords provided by ORA, Inc.:
Non-exudative age-related macular degeneration

Additional relevant MeSH terms:
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases processed this record on August 23, 2017